Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience

医学 鼻咽癌 放射治疗 化疗 诱导化疗 咽痛 阶段(地层学) 回顾性队列研究 癌 内科学 放化疗 外科 肿瘤科 古生物学 生物 食管
作者
A. Jouin,Sylvie Helfré,Stéphanie Bolle,L. Claude,A. Laprie,Émilie Bogart,C. Vigneron,H. Potet,A. Ducassou,Audrey Claren,F.-G. Riet,Marie Pierre Castex,Cécile Faure‐Conter,Brice Fresneau,Anne‐Sophie Defachelles,Daniel Orbach
出处
期刊:Strahlentherapie Und Onkologie [Springer Science+Business Media]
卷期号:195 (6): 504-516 被引量:21
标识
DOI:10.1007/s00066-019-01461-6
摘要

The aim of this study was to retrospectively study survival and long-term morbidities of children with nasopharyngeal carcinoma (NPC) treated by induction chemotherapy and concurrent chemoradiation (CRT). The total dose of radiation was adapted to the response following neoadjuvant chemotherapy. Children with non-metastatic NPC treated in France between 1999 and 2015 were retrospectively included in the study. The strategy combined neoadjuvant platinum-based chemotherapy, followed by adapted CRT to tumor response. In total, 95 patients (median age 15 years [range, 7–23 years], male-to-female ratio 1.8) with undifferentiated NPC were included; 59% of patients had TNM stage IV. Intensity-modulated radiotherapy (IMRT) was delivered to 57 patients (60%), while the other patients were treated with conformal RT (3D-RT). After a median follow-up of 4.5 years [range, 3.6–5.5 years], 13 relapses and seven deaths had occurred. The 3‑year overall and relapse-free survival (RFS) were 94% [95% CI, 85–97%] and 86% [77–92%], respectively. The locoregional failure rate was 6% [95% CI, 2–14]. Long-term treatment-related sequelae of grade 2+ were reported by 37 (50%) patients; odynophagia was significantly reduced treated by IMRT vs. conventional 3D-RT (7% vs. 55%, p = 0.015). Using a reduction dose of 59.4 Gy, 54 Gy, and 45 Gy, respectively, to the primary, involved, and uninvolved neck nodes, after a favorable tumor response, was not associated with an increased locoregional failure rate. The survival rates for NPC have been considerably improved by means of multimodal therapy, but long-term locoregional morbidity remains common. Use of IMRT may induce less residual odynophagia. Radiation dose reduction adapted to chemotherapy response does not have a negative impact on outcome. These findings support the use of an RT protocol adapted to the tumor response to neoadjuvant chemotherapy for a long-lasting improvement in the patient’s quality of life.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
wuhan发布了新的文献求助10
1秒前
LIANGMEIHAO发布了新的文献求助10
2秒前
生动若云完成签到,获得积分10
2秒前
2秒前
3秒前
冷静以山完成签到 ,获得积分10
3秒前
Kevin发布了新的文献求助10
4秒前
只要两毛九完成签到,获得积分10
4秒前
zhaoyuli发布了新的文献求助10
4秒前
4秒前
5秒前
不安听露完成签到 ,获得积分10
5秒前
香蕉觅云的应助被伊莎贝拉采纳,获得10
5秒前
5秒前
王英俊完成签到,获得积分10
5秒前
fhg关闭了fhg的文献求助
6秒前
alina发布了新的文献求助10
6秒前
6秒前
万能图书馆的应助被复杂从梦采纳,获得10
7秒前
Drlee发布了新的文献求助10
8秒前
caidan完成签到,获得积分10
8秒前
8秒前
8秒前
Leavome完成签到,获得积分10
9秒前
9秒前
9秒前
喜洋羊发布了新的文献求助10
9秒前
Ava的应助被一口一个汤包采纳,获得10
9秒前
吴糖气泡水完成签到,获得积分10
9秒前
星辰大海的应助被土娃子采纳,获得10
9秒前
dde发布了新的文献求助10
10秒前
今后的应助被laohanyin采纳,获得10
11秒前
gby完成签到,获得积分10
11秒前
susie233发布了新的文献求助10
12秒前
慕青的应助被LIANGMEIHAO采纳,获得10
12秒前
12秒前
chuhan完成签到,获得积分10
13秒前
13秒前
尤尤完成签到 ,获得积分20
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1080
Encyclopedia of Modern Artificial Intelligence 1000
Особенности технологий и методов информационно-психологических войн СССР с Великобританией и США в период 1939-1953 гг 1000
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Cellulose and Cellulose Derivatives: Synthesis, Modification and Applications 600
Experimentelle und numerische Modellierung des dynamischen Trag- und Verformungsverhaltens von hochflexiblen Schutzsystemen gegen Steinschlag 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8149893
求助须知:如何正确求助?哪些是违规求助? 9546952
关于积分的说明 21678753
捐赠科研通 7736911
什么是DOI,文献DOI怎么找? 3424215
关于科研通互助平台的介绍 2549173
邀请新用户注册赠送积分活动 2467417